TEL AVIV, Israel--(BUSINESS WIRE)--Compugen Ltd. (NASDAQ: CGEN) today announced that it will host a live webcast and conference call at 10:00 AM EDT on Tuesday, July 27, 2010 to review second quarter 2010 results. In addition, Dr. Anat Cohen-Dayag, Compugen’s president and CEO, will give a slide presentation illustrating the medical and commercial potential of the Company’s “discovery on demand” capabilities using Compugen’s recently announced product candidate for autoimmune disease, CGEN-15001, as an example. The quarterly results will be released, and the slide presentation posted on the Company’s website (www.cgen.com) and at the following link, prior to the conference call.
